Ovarian cancer does produce a distinct odor, but it’s far too faint for humans to notice on their own. The smell comes from volatile organic compounds (VOCs) released by cancer cells as a byproduct of their abnormal metabolism. These chemical signatures have been detected in blood, breath, and urine samples using trained dogs and specialized sensor technology, often with remarkable accuracy.
Why Cancer Cells Produce an Odor
Cancer cells burn through energy differently than healthy cells. Their metabolism is faster, less regulated, and produces a unique set of waste products, including VOCs that enter the bloodstream and eventually show up in breath, urine, and blood plasma. In ovarian cancer specifically, researchers have identified fatty acids and short-chain aldehydes as part of this chemical fingerprint. The concentrations in blood are extremely low, which is why detection requires either a highly sensitive biological nose or an advanced sensor array rather than a standard lab test.
One particularly striking finding is that the VOC pattern from ovarian cancer appears to be unique to that disease. A study training dogs on tissue samples found that the odor of ovarian carcinomas differed from other gynecological cancers, including cervical, endometrial, and vulvar cancers. This suggests ovarian cancer has its own chemical signature, not just a generic “cancer smell.”
Trained Dogs Can Detect It With High Accuracy
The strongest evidence for ovarian cancer having a detectable scent comes from canine studies. In one study, dogs trained on ovarian cancer tissue samples achieved 100% sensitivity and 97.5% specificity in double-blind tests, meaning they correctly identified nearly every cancer sample and almost never flagged a healthy sample by mistake. The dogs could distinguish between different types and grades of ovarian tumors, including borderline (early or low-grade) tumors.
A separate study tested whether dogs could detect ovarian cancer from blood plasma alone. In that trial, the dogs reached 97% sensitivity and 99% specificity. When the same patients were tested again three months after treatment, accuracy dropped to 70% sensitivity and 95% specificity, then shifted to 80% sensitivity and 92% specificity at six months. This pattern makes sense: as treatment reduces the tumor burden, fewer cancer-related VOCs circulate in the blood, giving the dogs less to work with.
Importantly, the dogs’ ability to detect the cancer was not affected by the patient’s age, menopausal status, tumor stage, or tumor grade. This is significant because ovarian cancer is notoriously difficult to catch early, and most current screening tools perform poorly for early-stage disease.
Electronic Noses Are Catching Up
Researchers have been working to replicate what dogs can do using electronic devices called “e-noses.” These sensor arrays analyze chemical patterns in breath, urine, or blood and use algorithms to classify samples as cancerous or healthy. A large meta-analysis of e-nose studies across multiple cancer types found that for ovarian cancer, the technology achieved roughly 86% sensitivity and 92% specificity overall.
Individual studies have shown even more dramatic results. One Italian study using an e-nose on breath samples reported 100% accuracy in distinguishing ovarian cancer patients from both healthy controls and patients with benign ovarian masses. Other studies, particularly when trying to separate ovarian cancer from benign tumors (a harder task), saw accuracy drop closer to 60%. The technology works best when combining data from multiple sample types. One research team found that no single body fluid (breath, urine, blood, or plasma) was reliable enough on its own, but merging sensor data from all of them into a combined profile significantly improved classification.
Can You Smell It Yourself?
No. The VOCs associated with ovarian cancer exist at concentrations far below what the human nose can perceive. There are no reliable reports of patients or partners noticing a characteristic odor before diagnosis. While the CDC lists unusual vaginal discharge as a possible symptom of ovarian cancer, this refers to changes in the discharge itself, not a distinctive smell that would point specifically to cancer.
If you’ve noticed a new or unusual odor from vaginal discharge, that’s worth mentioning to a doctor, but it’s far more commonly linked to infections, hormonal changes, or other non-cancerous conditions than to ovarian cancer. The classic symptoms of ovarian cancer are persistent bloating, pelvic or abdominal pain, difficulty eating or feeling full quickly, and urinary changes like increased frequency or urgency.
Why This Matters for Early Detection
Ovarian cancer is one of the deadliest gynecological cancers largely because it’s usually caught late. There is no widely recommended screening test for the general population, and symptoms are vague enough to be mistaken for digestive or urinary issues for months. A reliable, non-invasive screening tool based on scent detection could change that picture dramatically.
The fact that trained dogs can detect even borderline tumors, and that their accuracy holds across different stages and grades, suggests the VOC signal appears early in the disease. E-nose technology is not yet ready for clinical use, but the accuracy numbers from recent studies are promising enough that researchers consider it a realistic candidate for future screening programs. The goal would be a quick, painless breath or blood test that flags patients for further imaging, catching the disease at a stage when treatment is most effective.